Michael Taylor
Family Medicine · Summersville, WVNPI 1770683203
Payments from drug & device makers
Across 208 payments — averaging $18.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$566
- Abbott$428
- Novo Nordisk$366
- AstraZeneca$213
- Dexcom, Inc.$213
- Amgen$196
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,747100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $566 |
| Abbott | 21 | $428 |
| Novo Nordisk | 23 | $366 |
| AstraZeneca | 14 | $213 |
| Dexcom, Inc. | 13 | $213 |
| Amgen | 14 | $196 |
| Lilly USA, LLC | 12 | $186 |
| Johnson & Johnson(2 entities) | 6 | $151 |
| E.r. Squibb & Sons, L.L.C. | 10 | $147 |
| Mylan Specialty L.p. | 6 | $124 |
| Insulet Corporation | 5 | $114 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $104 |
| Phathom Pharmaceuticals, Inc. | 1 | $95 |
| Astellas Pharma US Inc | 5 | $95 |
| Novartis | 5 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $77 |
| Boehringer Ingelheim | 5 | $74 |
| Tandem Diabetes Care, Inc. | 4 | $63 |
| Pfizer | 3 | $53 |
| Averitas Pharma Inc. | 3 | $51 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Verona Pharma, Inc. | 2 | $43 |
| GSK | 2 | $41 |
| Nestle Healthcare Nutrition Inc. | 2 | $36 |
| Exact Sciences | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $28 |
| Recor Medical Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Rhythm Pharmaceuticals, Inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| Merck | 1 | $11 |
| Kvk-tech, Inc. | 1 | $2 |
How this compares
$3,747 in reported general payments places this provider in the 85th percentile of 843 family medicine providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 283 | $287,332 |
| MounjaroTirzepatide | 128 | $162,439 |
| XareltoRivaroxaban | 111 | $119,907 |
| OzempicSemaglutide | 99 | $117,103 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 86 | $90,224 |
| JanuviaSitagliptin Phosphate | 54 | $64,820 |
| JardianceEmpagliflozin | 47 | $61,261 |
| EntrestoSacubitril/Valsartan | 38 | $51,213 |
| LinzessLinaclotide | 69 | $51,067 |
| Tresiba Flextouch U-100Insulin Degludec | 48 | $49,355 |
| FarxigaDapagliflozin Propanediol | 21 | $31,642 |
| JanumetSitagliptin Phos/Metformin Hcl | 19 | $30,993 |
| Tresiba Flextouch U-200Insulin Degludec | 24 | $29,243 |
| Breo ElliptaFluticasone/Vilanterol | 44 | $22,997 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 41 | $20,057 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Premarin | $53 | $296,410314 claims |
| Lilly USA, LLCMounjaro, Trulicity | $186 | $181,085148 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $41 | $146,421200 claims |
| Johnson & JohnsonXarelto | $151 | $119,907111 claims |
| Novo NordiskOzempic | $366 | $117,10399 claims |
| MerckJanuvia, Janumet | $11 | $95,81273 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Tradjenta | $74 | $92,35389 claims |
| AbbVieLinzess, Vraylar | $566 | $68,52281 claims |
| NovartisEntresto | $83 | $51,21338 claims |
| AstraZenecaFarxiga, Bevespi Aerosphere | $213 | $36,20632 claims |
| Astellas Pharma US IncMyrbetriq | $95 | $8,20516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Summersville
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
- Ryan RunyonPrinceton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.